MAKENZIE DRISCOLL: Open Payments
NPI 1588297527 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 30 payments from 10 companies in 2025. Trend: 2023 $119 · 2024 $294 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Avita Medical Americas, LLC | 10 | $235 |
| Smith+Nephew, Inc. | 10 | $168 |
| Pacira Pharmaceuticals Incorporated | 2 | $80 |
| Solventum Corporation | 2 | $43 |
| Innovation Technologies Inc | 1 | $31 |
| Ethicon US, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $22 |
| Organogenesis Inc. | 1 | $20 |
| Davol Inc. | 1 | $19 |
| Kerecis Limited | 1 | $17 |
Products named: Permeaderm, Exparel, Recell, COLLAGENASE SANTYL, STRAVIX PL, Pico 14, ACTIV.A.C., IRRISEPT.
Industry payments across IA — which companies pay providers there.
